VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr | ₹-162 Cr | ₹-73 Cr |
What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.08 Cr |
Mar2023 | ₹-0.57 Cr |
Mar2022 | ₹-9.48 Cr |
Mar2021 | ₹-162 Cr |
Mar2020 | ₹-73 Cr |
How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.08 Cr | Negative | |
Mar2023 | ₹-0.57 Cr | Negative | |
Mar2022 | ₹-9.48 Cr | Negative | |
Mar2021 | ₹-162 Cr | Negative | |
Mar2020 | ₹-73 Cr | - |
Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹412.1 Cr | -2.7% | 4% | -13.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,608.0 Cr | -3.9% | -6.7% | 11.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,383.0 Cr | -1.4% | 1.8% | 56.7% | Stock Analytics | |
CIPLA | ₹118,239.0 Cr | -0.6% | 1.7% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,187.7 Cr | -4.8% | -10.2% | -6.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹89,695.7 Cr | -5.4% | -8.9% | 0.6% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -2.7% |
4% |
-13.2% |
SENSEX | -0.3% |
0.1% |
4.9% |
You may also like the below Video Courses